REPLIMUNE GROUP, INC.

Transcripts Replimune Group, Inc.

Equities

REPL

US76029N1063

Market Closed - Nasdaq Other stock markets 21:00:00 10/05/2024 BST			5-day change	1st Jan Change
6.41 ^USD	-4.75%		-7.77%	-23.96%

04-08	Replimune Group Provides Interim Results for Skin Cancer Therapy	MT
03-26	Replimune Group, Inc. Announces Management Changes	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Replimune Group, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-14-2024 10:45 AM	03-14
Transcript : Replimune Group, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 11:15 AM	01-08
Transcript : Replimune Group, Inc. - Special Call	12-05
Transcript : Replimune Group, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 09:45 AM	09/01/23
Transcript : Replimune Group, Inc. - Special Call	07/12/22
Transcript : Replimune Group, Inc. - Shareholder/Analyst Call	07/09/22
Transcript : Replimune Group, Inc. - Analyst/Investor Day	30/03/22
Transcript : Replimune Group, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-10-2022 07:30 AM	10/01/22
Transcript : Replimune Group, Inc. - Shareholder/Analyst Call	08/09/21
Transcript : Replimune Group, Inc. - Special Call	03/06/21
Transcript : Replimune Group, Inc. Presents at Barclays Global Healthcare Conference 2021, Mar-11-2021 09:10 AM	11/03/21
Transcript : Replimune Group, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-12-2021 02:20 PM	12/01/21
Transcript : Replimune Group, Inc. - Special Call	03/06/20
Transcript : Replimune Group, Inc. Presents at 38th Annual J.P Morgan Healthcare Conference, Jan-14-2020 05:00 PM	15/01/20
Transcript : Replimune Group, Inc. - Special Call	08/11/19
Transcript : Replimune Group, Inc. Presents at JP Morgan 37th Annual Healthcare conference, Jan-09-2019 08:00 AM	09/01/19
Replimune Group, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended September 30, 2018; Provides Earnings Guidance for the Second Half of 2021	14/11/18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer